Clinical trial

A Randomized, Dose-ranging Study of Alferon LDO in Asymptomatic HIV+ Subjects

NCT00215852

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2005-07-01

PhasePHASE2

Study timeline

Study start (unknown)2005-07-01Date precision: month

Registry last updated2013-09-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

Interventions

Alferon LDODRUG

Sponsors & collaborators

AIM ImmunoTech Inc.lead sponsor

Mapped research locations

PhiladelphiaPennsylvania, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00215852 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.